Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

GeoVax Labs, Inc. Director's Dealing 2021

Dec 8, 2021

35063_dirs_2021-12-08_2ecd1e72-f5c5-4fe5-9fd0-f5fb596f8e52.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: GeoVax Labs, Inc. (GOVX)
CIK: 0000832489
Period of Report: 2021-12-07

Reporting Person: DODD DAVID A (Director, President, CEO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-12-07 Stock Option (right to buy) $3.82 A 103000 Acquired 2031-12-07 Common Stock (103000) Direct

Footnotes

F1: Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.